NASSIM NABAVI: Open Payments
NPI 1205297983 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 17 payments from 8 companies in 2025. Trend: 2023 $2,739 · 2024 $2,518 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $164 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| Biogen, Inc. | 1 | $23 |
| SCILEX PHARMACEUTICALS INC. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| ACADIA Pharmaceuticals Inc | 1 | $20 |
| KYOWA KIRIN, INC. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: QULIPTA, VRAYLAR, PURIFIED CORTROPHIN GEL, AVONEX, UBRELVY, ZTLido, Auvelity, NUPLAZID.
Industry payments across GA — which companies pay providers there.
